Pulmonary Tuberculosis-Related Ischemic Stroke: A Retrospective Case Control Study

References

• Berger CA, Alipanah N, Kheir F, et al. Summary for clinicians: 2019 clinical practice guideline summary for the treatment of drug-resistant tuberculosis. Ann Am Thorac Soc. 2020;17(8):911–917. doi:10.1513/AnnalsATS.202004-318CME
   PubMed Web of Science ®Google Scholar
• Eisinger RW, Embry AC, Read SW, Fauci AS. 2019: a banner year for tuberculosis research. J Infect Dis. 2020;222(11):1768–1771. doi:10.1093/infdis/jiaa051
   PubMed Web of Science ®Google Scholar
• Solomons RS, Nieuwoudt ST, Seddon JA, van Toorn R. Risk factors for ischemic stroke in children with tuberculous meningitis. Childs Nerv Syst. 2021;37(8):2625–2634. doi:10.1007/s00381-021-05163-2
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang X, Li H, Chen G, Zhu M. Acute ischemic stroke in young adults with tuberculous meningitis. BMC Infect Dis. 2019;19(1):362. doi:10.1186/s12879-019-4004-5
   PubMed Web of Science ®Google Scholar
• Misra UK, Kalita J, Maurya PK. Stroke in tuberculous meningitis. J Neurol Sci. 2011;303(1–2):22–30. doi:10.1016/j.jns.2010.12.015
   PubMed Web of Science ®Google Scholar
• Schoeman JF, Rutherfoord GS, Hewlett RH. Acute stroke in a child with miliary tuberculosis. Clin Neuropathol. 1997;16(6):303–308.
   PubMed Web of Science ®Google Scholar
• Arulprakash N, Narayanan L, Narayanan S, Young A. Patient with stroke and primary tuberculosis. J Neurosci Rural Pract. 2018;9(4):613–615. doi:10.4103/jnrp.jnrp_59_18
   PubMed Web of Science ®Google Scholar
• Briones-Claudett K, Briones-Claudett M, Briones Zamora K, et al. Ischemic stroke and disseminated tuberculosis in intensive care: a case report. Am J Case Rep. 2020;21:e920410. doi:10.12659/AJCR.920410
   PubMed Web of Science ®Google Scholar
• Radmanesh F, Nejat F, El Khashab M. Cerebral infarction as the first presentation of tuberculosis in an infant: a case report. J Microbiol Immunol Infect. 2010;43(3):249–252. doi:10.1016/S1684-1182(10)60039-4
   PubMedGoogle Scholar
• Sheu J, Chiou H, Kang J, Chen Y, Lin H. Tuberculosis and the risk of ischemic stroke: a 3-year follow-up study. Stroke. 2010;41(2):244–249. doi:10.1161/STROKEAHA.109.567735
   PubMed Web of Science ®Google Scholar
• Wu C, Chen L, Yen M, et al. Does non-central nervous system tuberculosis increase the risk of ischemic stroke? A population-based propensity score-matched follow-up study. PLoS One. 2014;9(7):e98158. doi:10.1371/journal.pone.0098158
   PubMed Web of Science ®Google Scholar
• Wilson D, Moosa MS, Cohen T, et al. Evaluation of tuberculosis treatment response with serial C-reactive protein measurements. Open Forum Infect Dis. 2018;5(11):ofy253. doi:10.1093/ofid/ofy253
   PubMed Web of Science ®Google Scholar
• Kirwan DE, Chong DLW, Friedland JS. Platelet activation and the immune response to tuberculosis. Front Immunol. 2021;12:631–696. doi:10.3389/fimmu.2021.631696
   Web of Science ®Google Scholar
• Cudahy PGT, Warren JL, Cohen T, Wilson D. Trends in C-reactive protein, D-Dimer, and fibrinogen during therapy for HIV-associated multidrug-resistant tuberculosis. Am J Trop Med Hyg. 2018;99(5):1336–1341. doi:10.4269/ajtmh.18-0322
   PubMed Web of Science ®Google Scholar
• Shantikumar S, Grant PJ, Catto AJ, Bamford JM, Carter AM. Elevated C-reactive protein and long-term mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation. Stroke. 2009;40(3):977–979. doi:10.1161/STROKEAHA.108.525105
   PubMed Web of Science ®Google Scholar
• Kollikowski AM, Pham M, März AG, et al. Platelet activation and chemokine release are related to local neutrophil-dominant inflammation during hyperacute human stroke. Transl Stroke Res. 2021;13(3):364–369. doi:10.1007/s12975-021-00938-w
   PubMed Web of Science ®Google Scholar
• Ferreira JP, Lam CSP, Anker SD, et al. Plasma D-dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER-HF trial. Eur J Heart Fail. 2021;23(4):648–656. doi:10.1002/ejhf.2003
   PubMed Web of Science ®Google Scholar
• Alvarez-Perez FJ, Castelo-Branco M, Alvarez-Sabin J. Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke. J Neurol Neurosurg Psychiatry. 2011;82(9):986–992. doi:10.1136/jnnp.2010.230870
   PubMed Web of Science ®Google Scholar
• Kono T, Ohtsuki T, Hosomi N, et al. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer. Geriatr Gerontol Int. 2012;12(3):468–474. doi:10.1111/j.1447-0594.2011.00796.x
   PubMed Web of Science ®Google Scholar
• Bang OY, Seok JM, Kim SG, et al. Ischemic stroke and cancer: stroke severely impacts cancer patients, while cancer increases the number of strokes. J Clin Neurol. 2011;7(2):53–59. doi:10.3988/jcn.2011.7.2.53
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 Guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–e418. doi:10.1161/STR.0000000000000211
   PubMed Web of Science ®Google Scholar
• Draznin B, Aroda VR, Bakris G, et al. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–s38.
   PubMedGoogle Scholar
• Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2019;73(24). e285–e350.
   PubMed Web of Science ®Google Scholar
• Nahid P, Mase SR, Migliori GB, et al. Treatment of drug-resistant tuberculosis. an official ATS/CDC/ERS/IDSA clinical practice guideline. Am J Respir Crit Care Med. 2019;200(10):e93–e142. doi:10.1164/rccm.201909-1874ST
   PubMed Web of Science ®Google Scholar
• Garg RK, Sharma R, Kar AM, et al. Neurological complications of miliary tuberculosis. Clin Neurol Neurosurg. 2010;112(3):188–192. doi:10.1016/j.clineuro.2009.11.013
   PubMed Web of Science ®Google Scholar
• Hsieh FY, Chia LG, Shen WC. Locations of cerebral infarctions in tuberculous meningitis. Neuroradiology. 1992;34(3):197–199. doi:10.1007/BF00596334
   PubMed Web of Science ®Google Scholar
• Kager LM, Blok DC, Lede IO, et al. Pulmonary tuberculosis induces a systemic hypercoagulable state. J Infect. 2015;70(4):324–334. doi:10.1016/j.jinf.2014.10.006
   PubMed Web of Science ®Google Scholar
• Robson SC, White NW, Aronson I, et al. Acute-phase response and the hypercoagulable state in pulmonary tuberculosis. Br J Haematol. 1996;93(4):943–949. doi:10.1046/j.1365-2141.1996.d01-1722.x
   PubMed Web of Science ®Google Scholar
• Ntolios P, Papanas N, Nena E, et al. Mean platelet volume as a surrogate marker for platelet activation in patients with idiopathic pulmonary fibrosis. Clin Appl Thromb Hemost. 2016;22(4):346–350. doi:10.1177/1076029615618023
   PubMed Web of Science ®Google Scholar
• Lee MY, Kim YJ, Lee HJ, Cho SY, Park TS. Mean platelet volume in Mycobacterium tuberculosis infection. Biomed Res Int. 2016;2016:7508763. doi:10.1155/2016/7508763
   PubMed Web of Science ®Google Scholar
• Cumpelik A, Gerossier E, Jin J, et al. Mechanism of platelet activation and hypercoagulability by Antithymocyte Globulins (ATG). Am J Transplant. 2015;15(10):2588–2601. doi:10.1111/ajt.13316
   PubMed Web of Science ®Google Scholar
• Membre A, Wahl D, Latger-Cannard V, et al. The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies. Haematologica. 2008;93(4):566–573. doi:10.3324/haematol.12364
   PubMed Web of Science ®Google Scholar
• Freedman J, Mody M, Lazarus AH, et al. Platelet activation and hypercoagulability following treatment with porcine factor VIII (HYATE:C). Am J Hematol. 2002;69(3):192–199. doi:10.1002/ajh.10057
   PubMed Web of Science ®Google Scholar
• Ramos-Pachón A, López-Cancio E, Bustamante A, et al. D-dimer as predictor of large vessel occlusion in acute ischemic stroke. Stroke. 2021;52(3):852–858. doi:10.1161/STROKEAHA.120.031657
   PubMed Web of Science ®Google Scholar
• Hou H, Xiang X, Pan Y, et al. Association of level and increase in D-dimer with all-cause death and poor functional outcome after ischemic stroke or transient ischemic attack. J Am Heart Assoc. 2021;10(3):e018600. doi:10.1161/JAHA.120.018600
   PubMed Web of Science ®Google Scholar
• Min W, Zi-Feng J, Jian-Lin X, Hao-Hui F. Role of the fibrinogen degradation products and D-dimer in the differential diagnosis of pulmonary tuberculosis and community-acquired pneumonia. Clin Lab. 2018;64(1):135–140. doi:10.7754/Clin.Lab.2017.170720
   PubMed Web of Science ®Google Scholar
• Gon Y, Sakaguchi M, Takasugi J, et al. Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke. Eur J Neurol. 2017;24(3):503–508. doi:10.1111/ene.13234
   PubMed Web of Science ®Google Scholar
• Seok JM, Kim SG, Kim JW, et al. Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol. 2010;68(2):213–219. doi:10.1002/ana.22050
   PubMed Web of Science ®Google Scholar
• Chao BH, Yan F, Hua Y, et al. Stroke prevention and control system in China: CSPPC-stroke program. Int J Stroke. 2021;16(3):265–272. doi:10.1177/1747493020913557
   PubMed Web of Science ®Google Scholar